Fleischmann, Achim; Rotzer, Diana; Seiler, Roland; Studer, Urs E; Thalmann, George N (2011). Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours. European urology, 60(2), pp. 350-7. Amsterdam: Elsevier 10.1016/j.eururo.2011.05.035
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
1-s2.0-S0302283811005240-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) |
Her2, an alias for the protein of v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian), might be an attractive therapeutic target in metastasising bladder cancer. Genotype and phenotype of primary tumours and their metastases may differ.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Service Sector > Institute of Pathology 04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology 04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology |
UniBE Contributor: |
Fleischmann, Achim, Rotzer, Diana, Seiler-Blarer, Roland, Studer, Urs, Thalmann, George |
ISSN: |
0302-2838 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:18 |
Last Modified: |
29 Jun 2023 14:37 |
Publisher DOI: |
10.1016/j.eururo.2011.05.035 |
PubMed ID: |
21640482 |
Web of Science ID: |
000291977400034 |
BORIS DOI: |
10.48350/5479 |
URI: |
https://boris.unibe.ch/id/eprint/5479 (FactScience: 210226) |
Actions (login required)
 |
Edit item |